EUFOREA consensus on biologics for CRSwNP with or without asthma.
Wytske J Fokkens, Valerie Lund, Claus Bachert...
https://pubmed.ncbi.nlm.nih.gov/31090937/Actively Recruiting
Led by Italian Academy of Rhinology · Updated on 2024-07-19
5000
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are collecting data from patients in Italy with severe, uncontrolled Chronic Rhinosinusitis CRS through a registry called the Rhinosinusitis Italian Network RINET. This observational study aims to better understand the progression of uncontrolled CRS, identify different types of the condition, evaluate various treatments used in real clinical settings, and support the development of new diagnostic and treatment methods. The study also seeks to raise awareness about CRS among patients, the public, and medical professionals such as otolaryngologists, allergists, and pneumologists. Participants will be treated by a multidisciplinary team including allergists, otolaryngologists, and pneumologists, reflecting real-life clinical care. The study collects information on the use and effects of treatments like systemic corticosteroids and records therapeutic decisions to understand their impact on the diseases natural course. Data will be gathered longitudinally from patients attending specialist centers across Italy. Participants will be followed over time with annual assessments, including the Nasal Polyp Score to monitor disease status. Other evaluations include quality of life measures, symptom scales, and biological markers of inflammation. The study aims to track clinical outcomes and the economic impact of treatments. Participation involves regular visits to specialist centers where clinical data, questionnaires, and laboratory samples may be collected to support a comprehensive understanding of uncontrolled CRS.
CONDITIONS
Rhinosinusitis Italian Network: the Italian Registry for Severe, Uncontrolled Chronic Rhinosinusitis
E
Enrico Marco Heffler, MD, PhD
C
Concetta Sirena, Dr.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Italian Academy of Rhinology
Lead Sponsor
Accademia Italiana di Citologia Nasale
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 10 years
Participants are observed over a long period to study the evolution and treatment outcomes of severe, uncontrolled Chronic Rhinosinusitis.
Annual visits
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Wytske J Fokkens, Valerie Lund, Claus Bachert...
https://pubmed.ncbi.nlm.nih.gov/31090937/W J Fokkens, V J Lund, C Hopkins...
https://pubmed.ncbi.nlm.nih.gov/32077450/Italian Academy of Rhinology
Lead Sponsor
Accademia Italiana di Citologia Nasale
Collaborating Sponsor